Harrington PR, Cong J, Troy SB, Rawson JMO, et al. Evaluation of SARS-CoV-2 RNA Rebound After Nirmatrelvir/Ritonavir Treatment in Randomized, Double-Blind, Placebo-Controlled Trials - United States and International Sites, 2021-2022. MMWR Morb Mortal Wkly Rep 2023;72:1365-1370.
PMID: 38127674